Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Human stem cells represent a potential source for implants that replace the depleted functional beta cell mass (FBM) in diabetes patients. Human embryonic stem cell-derived pancreatic endoderm (hES-PE) can generate implants with glucose-responsive beta cells capable of reducing hyperglycemia in mice. This study with device-encapsulated hES-PE (4 × 10 6 cells/mouse) determines the biologic characteristics at which implants establish metabolic control during a 50-week follow-up. A metabolically adequate FBM was achieved by (1) formation of a sufficient beta cell number (>0.3 × 10 6 /mouse) at >50% endocrine purity and (2) their maturation to a functional state comparable with human pancreatic beta cells, as judged by their secretory responses during perifusion, their content in typical secretory vesicles, and their nuclear NKX6.1-PDX1-MAFA co-expression. Assessment of FBM in implants and its correlation with in vivo metabolic markers will guide clinical translation of stem cell-derived grafts in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Generation of Functional Human Pancreatic β Cells In Vitro
Pagliuca, F. W., Millman, J. R., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J. H., Peterson, Q. P., Greiner, D., & Melton, D. A. (2014) · Cell · doi:10.1016/j.cell.2014.09.040 · Cited by 2,025 · cited 3×
“…be efficiently differentiated to pancreatic endoderm (D’Amour et al., 2005, 2006) that forms beta cells following implantation in immune-deficient mice (Kroon et al., 2008; Rezania et al., 2012) or following further in vitro steps (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015).”
BackgroundInfluentialKroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1393 · Cited by 1,843 · cited 2×
“…be efficiently differentiated to pancreatic endoderm (D’Amour et al., 2005, 2006) that forms beta cells following implantation in immune-deficient mice (Kroon et al., 2008; Rezania et al., 2012) or following further in vitro steps (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015).”
BackgroundMethodInfluentialSelf-citationEfficient differentiation of human embryonic stem cells to definitive endoderm
D'Amour, K. A., Agulnick, A. D., Eliazer, S., Kelly, O. G., Kroon, E., & Baetge, E. E. (2005) · Nature Biotechnology · doi:10.1038/nbt1163 · Cited by 1,730
Self-citationReversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells
Rezania, A., Bruin, J. E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O'Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.3033 · Cited by 1,575 · cited 9×
“, 2012) or following further in vitro steps (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015).”
BackgroundMethodResultInfluentialControlled induction of human pancreatic progenitors produces functional beta‐like cells in vitro
Russ, H. A., Parent, A. V., Ringler, J. J., Hennings, T. G., Nair, G. G., Shveygert, M., Guo, T., Puri, S., Haataja, L., Cirulli, V., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591058 · Cited by 591
Rezania, A., Bruin, J. E., Riedel, M. J., Mojibian, M., Asadi, A., Xu, J., Gauvin, R., Narayan, K., Karanu, F., O’Neil, J. J., et al. (2012) · Diabetes · doi:10.2337/db11-1711 · Cited by 582 · cited 3×
“…be efficiently differentiated to pancreatic endoderm (D’Amour et al., 2005, 2006) that forms beta cells following implantation in immune-deficient mice (Kroon et al., 2008; Rezania et al., 2012) or following further in vitro steps (Pagliuca et al., 2014; Rezania et al., 2014; Russ et al., 2015).”
BackgroundInfluentialInactivation of specific β cell transcription factors in type 2 diabetes
Guo, S., Dai, C., Guo, M., Taylor, B., Harmon, J. S., Sander, M., Robertson, R. P., Powers, A. C., & Stein, R. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65390 · Cited by 520 · cited 1×
“It is consistent with previous work showing that not all insulin-positive cells in human adult islet tissue are MAFA positive (Guo et al., 2013).”
ResultA prevascularized subcutaneous device-less site for islet and cellular transplantation
Pepper, A. R., Gala-Lopez, B., Pawlick, R., Merani, S., Kin, T., & Shapiro, A. M. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3211 · Cited by 381 · cited 1×
“Since tissue healing and vascularization around implants are considered as important variables, (pre)treatment of the implant sites could positively direct their influence (Pepper et al., 2015).”
BackgroundAgulnick, A. D., Ambruzs, D. M., Moorman, M. A., Bhoumik, A., Cesario, R. M., Payne, J. K., Kelly, J. R., Haakmeester, C., Srijemac, R., Wilson, A. Z., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0079 · Cited by 248
Self-citationBruin, J. E., Rezania, A., Xu, J., Narayan, K., Fox, J. K., O’Neil, J. J., & Kieffer, T. J. (2013) · Diabetologia · doi:10.1007/s00125-013-2955-4 · Cited by 216
Cited by
Ramzy, A., Thompson, D. M., Ward-Hartstonge, K. A., Ivison, S., Cook, L., Garcia, R. V., Loyal, J., Kim, P. T. W., Warnock, G. L., Levings, M. K., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.10.003 · Cited by 342
Sex differences underlying pancreatic islet biology and its dysfunction
Gannon, M., Kulkarni, R. N., Tse, H. M., & Mauvais-Jarvis, F. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.05.017 · Cited by 133
“Information generated from studies of pancreas development and endocrine differentiation from multiple organisms has resulted in multistep directed-differentiation protocols that can convert human embryonic stem cells (hESCs) into pancreatic progenitor cells, which, several months following implantation into immunocom…”
BackgroundInfluentialEngineering islets from stem cells for advanced therapies of diabetes
Siehler, J., Blöchinger, A. K., Meier, M., & Lickert, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00262-w · Cited by 125
Wang, X., Maxwell, K. G., Wang, K., Bowers, D. T., Flanders, J. A., Liu, W., Wang, L.-H., Liu, Q., Liu, C., Naji, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb4601 · Cited by 119
Yang, K., O’Cearbhaill, E. D., Liu, S. S., Zhou, A., Chitnis, G. D., Hamilos, A. E., Xu, J., Verma, M. K. S., Giraldo, J. A., Kudo, Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101258118 · Cited by 58
Metadata
- Authors
- Robert, T., De Mesmaeker, I., Stangé, G. M., Suenens, K. G., Ling, Z., Kroon, E. J., & Pipeleers, D. G.
- Venue
- Stem Cell Reports
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 10
- Issue
- 3
- Pages
- 739-750
- ISSN
- 2213-6711 (ISSN-L)
- OpenAlex
- W2791583455
- Cited by
- 79
- References
- 12
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control. https://app.cochat.ai/papers/10.1016/j.stemcr.2018.01.040
- The paper
- Robert, T., De Mesmaeker, I., Stangé, G. M., Suenens, K. G., Ling, Z., Kroon, E. J., & Pipeleers, D. G. (2018). Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2018.01.040
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.